Mercachem Holding bv:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Mercachem Holding bv - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10904
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:20
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:オランダ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Mercachem Holding BV (Mercachem) is a research company that offers transparent chemistry services. The company provides services in the areas of discovery chemistry, medicinal chemistry, parallel chemistry and process research. Its parallel chemistry services include library design, chemical validation, library synthesis and purification services. Mercachem’s process research services comprise route scouting, reaction optimization, catalyst screening, GMP production and impurity research. The company also offers optimization of lead molecules towards clinical candidates. It operates through its synthesis laboratories and analytical facility in the Netherlands. Mercachem is headquartered in Nijmegen, the Netherlands.

Mercachem Holding bv – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Mercachem Holding bv, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Mercachem Holding bv, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Mercachem Holding bv, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Mercachem Holding bv, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Mercachem Holding bv, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Mercachem Holding bv, Pharmaceuticals & Healthcare, Deal Details 10
Asset Purchase 10
Mercachem to Acquire Laboratory and Pilot Scale Operations in Prague from Synthon 10
Partnerships 11
AiCuris Anti-infective Cures and Mercachem Enter into Research Agreement 11
Mercachem Forms Joint Venture with UbiQ Bio 12
Almirall Enters into Research Agreement with Mercachem 13
Mercachem Enters into Research Agreement with NB Health Lab 14
ProQinase Enters Into Co-Development Agreement With Mercachem For Drug Discovery Platform 15
Merger 16
Mercachem and Syncom Merge 16
Mercachem Holding bv – Key Competitors 17
Mercachem Holding bv – Key Employees 18
Mercachem Holding bv – Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Joint Venture 19
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20

List of Tables
Mercachem Holding bv, Pharmaceuticals & Healthcare, Key Facts 2
Mercachem Holding bv, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Mercachem Holding bv, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Mercachem Holding bv, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Mercachem Holding bv, Deals By Therapy Area, 2012 to YTD 2018 8
Mercachem Holding bv, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Mercachem to Acquire Laboratory and Pilot Scale Operations in Prague from Synthon 10
AiCuris Anti-infective Cures and Mercachem Enter into Research Agreement 11
Mercachem Forms Joint Venture with UbiQ Bio 12
Almirall Enters into Research Agreement with Mercachem 13
Mercachem Enters into Research Agreement with NB Health Lab 14
ProQinase Enters Into Co-Development Agreement With Mercachem For Drug Discovery Platform 15
Mercachem and Syncom Merge 16
Mercachem Holding bv, Key Competitors 17
Mercachem Holding bv, Key Employees 18
Mercachem Holding bv, Subsidiaries 19
Mercachem Holding bv, Joint Venture 19

List of Figures
Mercachem Holding bv, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Mercachem Holding bv, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Mercachem Holding bv, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Mercachem Holding bv, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Mercachem Holding bv, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Mercachem Holding bv, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Mercachem Holding bv, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Mercachem Holding bv, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Mercachem Holding bv:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • ICA Gruppen AB:企業のM&A・事業提携・投資動向
    ICA Gruppen AB - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's ICA Gruppen AB Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestmen …
  • Kedrion SpA:製薬・医療:M&Aディール及び事業提携情報
    Summary Kedrion SpA (Kedrion) collects and fractionates blood plasma to develop, produce and distribute plasma-derived therapies. The company’s products are used for the treatment of rare and serious disorders such as hemophilia, immune deficiency and neurological disorders. It also offers products …
  • Unchained Labs-製薬・医療分野:企業M&A・提携分析
    Summary Unchained Labs is a life science tools company which offers protein stability assessment products for biologics. Its product portfolio includes UNcle (biologics stability platform), HUNK (aggregation predictor), pUNk (protein sizing system), GRUNT (automated formulation preparation system), …
  • Foundation Radiology Group PC-医療機器分野:企業M&A・提携分析
    Summary Foundation Radiology Group PC (FRG) is a radiology solutions provider. The company provides radiological services in areas of pediatric, neurology, mammography, musculoskeletal, PET and CT, cardiac CT and interventional radiology. It provides imaging solutions for the radiologists and system …
  • Vistin Pharma AS (VISTIN):製薬・医療:M&Aディール及び事業提携情報
    Summary Vistin Pharma AS (Vistin), a subsidiary of Vistin Pharma ASA is a healthcare company that produces and supplies active pharmaceutical ingredients and solid dosage forms. The company’s products include opioids, an analgesics and antitussive; metformin, an API for the treatment of diabetes II; …
  • Activision Blizzard, Inc.:企業の戦略・SWOT・財務分析
    Activision Blizzard, Inc. - Strategy, SWOT and Corporate Finance Report Summary Activision Blizzard, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Pfenex Inc (PFNX)-製薬・医療分野:企業M&A・提携分析
    Summary Pfenex Inc (Pfenex) is a biologics company that develops biosimilar therapeutics. The company’s lead product candidate includes, PF582, a biosimilar candidate which is used for the treatment of retinal diseases. It also develops PF530, a biosimilar candidate for the treatment of multiple scl …
  • J. Front Retailing Co., Ltd.:戦略・SWOT・企業財務分析
    J. Front Retailing Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary J. Front Retailing Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Phenex Pharmaceuticals AG:製薬・医療:M&Aディール及び事業提携情報
    Summary Phenex Pharmaceuticals AG (Phenex Pharmaceuticals) is a drug discovery and development company that offers nuclear receptors for the development of novel therapies. The company offer services such as NR selectivity screening, contract screening services, and SNuRM profiling to pharmaceutical …
  • KT Corporation:企業の戦略・SWOT・財務情報
    KT Corporation - Strategy, SWOT and Corporate Finance Report Summary KT Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Paramedical Srl:企業の製品パイプライン分析2018
    Summary Paramedical Srl (Paramedical) is a medical equipment company that manufactures clinical chemistry, turbidimetry and instruments for laboratories. The company’s products include in vitro diagnostics and equipment, automated immunoassay, brochure regents and instruments, centrifuges, chemistry …
  • Cynosure Inc (CYNO):企業の財務・戦略的SWOT分析
    Summary Cynosure Inc (Cynosure), a subsidiary of Hologic Inc, is a developer, manufacturer and supplier of light-based aesthetic and medical treatment systems. Its products facilitate non-invasive body contouring, skin revitalization and scar reduction, cellulite reduction, hair removal, gynecologic …
  • Novartis AG:企業のM&A・事業提携・投資動向
    Novartis AG - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Novartis AG Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, ca …
  • Endologix, Inc. (ELGX)-医療機器分野:企業M&A・提携分析
    Summary Endologix, Inc. (Endologix) is a medical device company. It undertakes the development, manufacturing and selling of minimally invasive treatments for aortic diseases. The company lays focus on its patented technology for the treatment of Abdominal Aortic Aneurysms (AAA). The company’s AAA p …
  • Thornton & Ross Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Thornton & Ross Ltd (Thornton & Ross), a subsidiary of Stada Arzneimittel AG is a supplier of medicines and healthcare products. The company offers over the counter pharmaceutical products. It also manufactures pharmaceutical creams, liquids and semi-solids. Thornton & Ross’ products compris …
  • China UnionPay Company Ltd:企業の戦略・SWOT・財務情報
    China UnionPay Company Ltd - Strategy, SWOT and Corporate Finance Report Summary China UnionPay Company Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Tullow Oil plc:企業の戦略・SWOT・財務情報
    Tullow Oil plc - Strategy, SWOT and Corporate Finance Report Summary Tullow Oil plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Nirulas Corner House Private Limited:企業の戦略・SWOT・財務情報
    Nirulas Corner House Private Limited - Strategy, SWOT and Corporate Finance Report Summary Nirulas Corner House Private Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • Armetheon Inc-製薬・医療分野:企業M&A・提携分析
    Summary Armetheon Inc (Armetheon) is a drug development company that develops novel small molecule drugs for treatment of cardiovascular diseases with high unmet medical need. The company develops anticoagulants and antibiotics that make use of the antibiotic resistance mechanisms to provide bacteri …
  • Intezyne Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Intezyne Inc (Intezyne) is a biotechnology company that develops product candidates for the treatment of various cancer tumors. The company offers anti-cancer agents and IVECT method to improve cancer therapy. It provides compounds that are cellular or molecularly targeted or have tumor-spec …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆